Three effective treatments for COVID-19 not (yet) in guidelines

Let's Talk ID

English - March 25, 2023 04:00 - 25 minutes - 17.7 MB - ★★★★ - 40 ratings
Science Health & Fitness Medicine disease idsa infectious medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Joining IDSA’s Board of Directors: A Clinician’s Perspective

Next Episode: Joining IDSA’s Board of Directors: Is it really only for senior career professionals?

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.

*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.